Form 4 for IDXX Idexx Laboratories
Accepted 2024-08-07 00:00:00 ET · period of report 2024-08-05 · accession 0000874716-24-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-07 | 2024-08-05 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | F - Tax | $455.08 | -170 | 81.7K | -0.2% | -$77.4K |
| D | 2024-08-07 | 2024-08-05 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | M - OptEx | $0.00 | +384 | 81.9K | +0.5% | $0 |
| D | 2024-08-07 | 2024-08-05 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | M - OptEx | — | -384 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-05 | F | D | 170 | $455.08 | 81,732.59 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-05 | M | A | 384 | $0.00 | 81,902.59 | D | — | — | (F1) Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024. |
| 3 | Derivative | Restricted Stock Unit | 2024-08-05 | M | D | 384 | — | 0 | D | — · — to — | 384 Common Stock | (F3) Not applicable. (F2) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning August 5, 2020. |